Berry to Showcase Latest Technologies for Fast-to-Market, Patient-Centric Solutions 10 Apr 11:27 PM (7 days ago)
Solutions for patient-centred drug delivery devices that enhance dosing, administration, and medication adherence will be the focus of Berry Global Healthcare’s participation at this year’s RDD (Respiratory Drug Delivery) Europe Conference, taking place at the Estoril Congress Centre, Estoril (Lisbon), Portugal from May 6th to 9th. The company’s Medical Devices team will present a wide […]
The post Berry to Showcase Latest Technologies for Fast-to-Market, Patient-Centric Solutions first appeared on World Pharma Today.
Rapid Screening-Differential Scanning Calorimeter for Antibody Drug Development 5 Apr 1:11 AM (13 days ago)
Ensuring the thermal balance and stability of an antibody drug product happens to be quite critical when it comes to maintaining quality and at the same time securing regulatory nod. The Rapid Screening-Differential Scanning Calorimeter (RS-DSC) from TA Instruments™ offers an effective solution to screen any sort of buffer formulations and also assess protein sequence […]
The post Rapid Screening-Differential Scanning Calorimeter for Antibody Drug Development first appeared on World Pharma Today.
Pharmaceutical Documentation Enters a New Era of Innovation 2 Apr 4:25 AM (16 days ago)
The future of pharmaceutical documentation is here – faster, smarter and compliant. That’s what World Pharma Today learnt from its recent interview with Docuvera. Striking the right chord between regulatory compliance and automation, Docuvera has indeed changed the way pharmaceutical documentation is being analyzed and executed. 1. How does Docuvera’s AI-driven approach transform the erstwhile traditional pharmaceutical […]
The post Pharmaceutical Documentation Enters a New Era of Innovation first appeared on World Pharma Today.
How Language Barriers Impact Non-Native English Speakers in Healthcare 28 Mar 9:34 PM (20 days ago)
Language barriers create significant challenges for non-native English speakers in healthcare settings. In the United States, English is the primary language, which complicates communication for non-English-speaking patients. These patients often struggle to describe symptoms, understand instructions, and navigate the healthcare system effectively. Miscommunication can lead to misdiagnosis, improper treatment, and poor health outcomes. As diversity […]
The post How Language Barriers Impact Non-Native English Speakers in Healthcare first appeared on World Pharma Today.
Steriline’s Advanced Filling Innovations Exhibited At Interphex 2025 27 Mar 4:47 AM (22 days ago)
New York City, March 25, 2025 – Steriline, a well-established European manufacturer of highly specialized robotic filling machines and complete aseptic filling/finishing lines, will attend Interphex, the leading global pharmaceutical and biotechnology event that fosters collaborations and provides a comprehensive view of advancements in the pharmaceutical industry. The company will welcome visitors on April 1-3, 2025 at stand 2537 in the Javits Center, NYC, […]
The post Steriline’s Advanced Filling Innovations Exhibited At Interphex 2025 first appeared on World Pharma Today.
FDA Approval of AMVUTTRA for ATTR Amyloidosis 27 Mar 4:06 AM (22 days ago)
Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics, has announced U.S. FDA approval of AMVUTTRA® (vutrisiran) for the treatment of cardiomyopathy associated with wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults. This approval makes AMVUTTRA the first and only U.S. FDA-approved therapeutic to address both cardiomyopathy and polyneuropathy (hATTR-PN) in ATTR amyloidosis. ATTR-CM is […]
The post FDA Approval of AMVUTTRA for ATTR Amyloidosis first appeared on World Pharma Today.
Rina-S Shows Promise in Advanced Ovarian Cancer 27 Mar 3:46 AM (22 days ago)
Genmab has reported encouraging findings from the Phase 2 RAINFOL-01 trial of rinatabart sesutecan (Rina-S®), an experimental folate receptor-alpha (FRα)-targeted, TOPO1 antibody-drug combination (ADC). Data from the B1 cohort of the trial showed encouraging antitumor efficacy in highly pre-treated patients with advanced ovarian cancer (OC) independent of FRα expression levels. Rina-S 120 mg/m2 Q3W showed […]
The post Rina-S Shows Promise in Advanced Ovarian Cancer first appeared on World Pharma Today.
Coronado Research Announce the Appointment of Gary Lyons as EVP Medical Affairs 27 Mar 1:47 AM (22 days ago)
London, UK: Coronado Research has appointed Gary Lyons as EVP Medical Affairs. Gary is a seasoned senior Medical Affairs leader with extensive strategic and operational implementation experience across the industry and product lifecycle. He has previously led agency business units and built strategic teams focused on delivering outstanding medical communication services at global and local levels – […]
The post Coronado Research Announce the Appointment of Gary Lyons as EVP Medical Affairs first appeared on World Pharma Today.
Global GenAI study reveals optimism and opportunities for healthcare and life sciences 26 Mar 11:46 PM (22 days ago)
Marlow, UK – Generative AI (GenAI) is at the forefront of global innovation in both healthcare and life sciences. To better understand how technology is being used, data and AI leader SAS and Coleman Parkes Research conducted a global, cross-industry survey of 237 life sciences and pharma leaders and 240 healthcare leaders who are decision makers […]
The post Global GenAI study reveals optimism and opportunities for healthcare and life sciences first appeared on World Pharma Today.
Pharma Support Powers Sofinnova Biotech Acceleration Fund 25 Mar 10:48 PM (23 days ago)
Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong Pharma Support European life sciences investment firm Sofinnova Partners has announced the final close of its second biotech acceleration fund, raising €165 million and surpassing its original target. The fund, Sofinnova Biovelocita II, now holds the title as the largest pan-European initiative of its kind, with […]
The post Pharma Support Powers Sofinnova Biotech Acceleration Fund first appeared on World Pharma Today.